PROXY Laboratories B.V. (“PROXY”) announces today the acquisition of MicroSafe Services (Leiden, the Netherlands), from Merck Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany.

MicroSafe is a microbiological contract laboratory that delivers a complete range of critical testing and consultancy services for the development and production of (bio)pharmaceuticals. In addition to offering the majority of bacteriology tests it is specialized in mycoplasma testing and in vitro virology testing.

Under the agreement, existing MicroSafe customers will have a seamless transition and uninterrupted service with PROXY’s takeover. The MicroSafe employees will be employed by PROXY. No other terms were disclosed.

Dr Ruud Santing, CEO of PROXY, says: “With this acquisition our portfolio of microbiological tests is significantly strengthened. In combination with our Analytical R&D and Manufacturing departments we can now offer a broad range of activities in high demand by biotech firms. We are excited to provide continued quality and service to our new customers and also look forward to expanding our offerings to this new customer base.”

Merck Millipore stated that the transaction is a good fit and creates a positive future for MicroSafe.

For further information, please contact:

Dr Marcel Langoor, CBO of PROXY, via telephone number +31-(0)71-5244080 or via email.

PROXY’s services, whether routine or tailor-made, cover the whole range of QC testing: from compendial testing of pharmaceutical raw materials and excipients to release testing of finished products. In addition, PROXY performs analytical method development and validation thereof.

Design and performance of stability studies, also includes investigation of stability indicating power of key analytical methods. Processes and facilities are supported by our design and validation of cleaning procedures and analytical testing of utility-systems (water, gases). As licensed manufacturer of sterile clinical trial medication we also store and distribute clinical samples to hospitals and other trial sites.

Key expertise at PROXY

• Quality Control testing

• Quality Assurance services and consultancy

• Analytical method development and validation

• Product, process and cleaning validations (chemical and microbiological)

• Validation of utility-systems (water, gases)

• Storage and distribution of (bio)pharmaceuticals for clinical trials

• Stability testing, including storage and stability indicating power investigations

• EU-import analysis and release

• Small scale manufacturing of sterile clinical trial medication

• Residual solvents determination using GC-MS

• Impurity profiling using UPLC-QTOF-MS

• Oligonucleotide analysis using UPLC-TQD-MS

• Monoclonal analysis using CE